| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 11/25/2010 | US20100297011 Isolated peptides and uses thereof |
| 11/25/2010 | US20100297009 Self-assembled polyhedral multimeric chemical structures |
| 11/25/2010 | US20100297008 Ganglioside associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 11/25/2010 | US20100297006 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER |
| 11/25/2010 | US20100297005 Nucleic acids and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer |
| 11/25/2010 | US20100297004 High affinity anti-prostate stem cell antigen (psca) antibodies for cancer targeting and detection |
| 11/25/2010 | US20100297003 Anti-human tenascin monoclonal antibody |
| 11/25/2010 | CA2797937A1 Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response |
| 11/25/2010 | CA2764931A1 Engineered type iv pilin of clostridium difficile |
| 11/25/2010 | CA2762587A1 A temperature sensitive vaccine strain of mycoplasma hyopneumoniae and uses thereof |
| 11/25/2010 | CA2762302A1 Compositions and methods for the therapy and diagnosis of influenza |
| 11/25/2010 | CA2762176A1 Marker differentially expressed in cancer stem cells and methods of using same |
| 11/25/2010 | CA2762044A1 Universal influenza vaccine based on recombinant modified vaccinia ankara virus (mva) |
| 11/25/2010 | CA2761762A1 Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders |
| 11/24/2010 | EP2253957A1 Methods for producing an immune response to tuberculosis. |
| 11/24/2010 | EP2253956A2 Immune response assessment method |
| 11/24/2010 | EP2253709A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 11/24/2010 | EP2253707A2 Expec-specific proteins, genes encoding them and uses thereof |
| 11/24/2010 | EP2253646A1 Anti-dual integrin antibody and compositions and conjugates comprising said antibody |
| 11/24/2010 | EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 11/24/2010 | EP2253331A1 Modulation of antibody formation in mammals, applicability in gene therapy and animal model generation |
| 11/24/2010 | EP2253316A1 serotonin 5-HT3 receptor antagonists for use in the treatment or prevention of vestibular deficits |
| 11/24/2010 | EP2252634A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus |
| 11/24/2010 | EP2252633A1 Anti-trka antibodies and derivatives thereof |
| 11/24/2010 | EP2252632A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
| 11/24/2010 | EP2252329A2 Elimination of immune responses to viral vectors |
| 11/24/2010 | EP2252326A1 Vaccine compositions |
| 11/24/2010 | EP2252275A2 Templated open flocs of anisotropic particles for enhanced pulmonary delivery |
| 11/24/2010 | EP2252269A1 Casein particles encapsulating therapeutically active agents and uses thereof |
| 11/24/2010 | EP1929303B1 Assay and kits therefor |
| 11/24/2010 | EP1898950B1 Galk1s as modifiers of the pten/akt pathway |
| 11/24/2010 | EP1896849B1 Antibodies against histone modifications for clinical diagnosis and prognosis of cancer |
| 11/24/2010 | EP1809737B1 Mature dendritic cell compositions and methods for culturing same |
| 11/24/2010 | EP1651263B1 Safe mutant viral vaccines |
| 11/24/2010 | EP1576143B1 Virus-like particles, methods of preparation, and immonogenic compositions |
| 11/24/2010 | EP1496742B1 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 11/24/2010 | EP1355919B1 Molecules with extended half-lives, compositions and uses thereof |
| 11/24/2010 | EP1326896B1 Human anti-cd40 antibodies |
| 11/24/2010 | EP1119371B1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 11/24/2010 | EP0804572B1 Fusion protein comprising bpTK7 |
| 11/24/2010 | EP0444181B2 C-erbb-2 external domain: gp75 |
| 11/24/2010 | CN1958610B Medication of guiding antibody for anti leukaemia in monocarpotic cellularity |
| 11/24/2010 | CN1745849B Human bivalent purified hydrophobia vaccine and its preparation |
| 11/24/2010 | CN1513553B Vero cell fick-borne encephalitis inactivated vaccine |
| 11/24/2010 | CN101896601A Method for producing dendritic cells |
| 11/24/2010 | CN101896504A Bivalent, bispecific antibodies |
| 11/24/2010 | CN101896503A Monoclonal antibody 175 targeting the EGF receptor and derivatives and uses thereof |
| 11/24/2010 | CN101896501A Antibody targeting osteoclast-related protein Siglec-15 |
| 11/24/2010 | CN101896202A Polypeptides with enhanced anti-inflammatory and decreased cytotoxic properties and relating methods |
| 11/24/2010 | CN101896201A Method for treating bone fracture with anti-sclerostin antibodies |
| 11/24/2010 | CN101896200A Method of inhibition of leukemic stem cells |
| 11/24/2010 | CN101896199A Pharmaceutical formulation comprising hepatitis B virus neutralizing human antibody |
| 11/24/2010 | CN101896198A Ligands of HVEM for treating hematologic malignancies and autoimmune diseases |
| 11/24/2010 | CN101896197A Novel polysaccharide immunogens from clostridium difficile |
| 11/24/2010 | CN101896196A Constructing a DNA chimera for vaccine development against leishmaniasis and tuberculosis |
| 11/24/2010 | CN101896195A Attenuated mycoplasma gallisepticum strains |
| 11/24/2010 | CN101896194A Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection |
| 11/24/2010 | CN101896191A System for delivery into a XCR1 positive cell and uses thereof |
| 11/24/2010 | CN101896177A Combinations of therapeutic agents for treating cancer |
| 11/24/2010 | CN101892200A Anti-H3N8 subtype equine influenza virus monoclonal antibody and application thereof |
| 11/24/2010 | CN101892198A Anti-anthrax lethal factor chimeric monoclonal antibody, and preparation method and application thereof |
| 11/24/2010 | CN101892189A Transformant for blocking effect of porcine somatostatin by oral immunization and application thereof |
| 11/24/2010 | CN101892175A Bovine capsular serotype A Pasteurella mutocida, validation identification and application thereof |
| 11/24/2010 | CN101892168A Pichiapastoris expression strain for recombinant duck interleukin 2 and construction method and application thereof |
| 11/24/2010 | CN101891825A Recombinant fusion proteins of hepatitis B core proteins and tuberculosis antigen or antigen fragments and application thereof |
| 11/24/2010 | CN101891820A Humanized anti-human von willebrand disease factor monoclonal antibody and application thereof |
| 11/24/2010 | CN101891818A Single-chain antibody in anti-human prostate-specific membrane antigen extracellular region and application thereof |
| 11/24/2010 | CN101891817A Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof |
| 11/24/2010 | CN101891816A Humanized monoclonal antibody IgG Fab fragment of dermatophagoides farinae 2 allergoid specificity as well as preparation method and application thereof |
| 11/24/2010 | CN101891814A Anti-osteopontin OPN monoclonal antibody and application thereof |
| 11/24/2010 | CN101891806A Anti-flavivirus envelope E protein monoclonal antibody and application thereof |
| 11/24/2010 | CN101891805A Human enterovirus 71 type specific polypeptide and application thereof |
| 11/24/2010 | CN101890163A Use of anti-tnfalpha antibodies and another drug |
| 11/24/2010 | CN101890162A New use of PEG-PCL-PEG (polyethylene glycol-polycaprolactone-polyethylene glycol) and antigen-assembled mixture |
| 11/24/2010 | CN101890161A Oligonucleotide composition adjuvant |
| 11/24/2010 | CN101890160A Multivalent recombinant human papilloma virus vaccine and application thereof |
| 11/24/2010 | CN101890159A Method for preparing bivalent inactivated vaccine of tilapia streptococcus |
| 11/24/2010 | CN101204580B Application of Vibrio alginolyticus-OmpA as animal immunity regulator |
| 11/24/2010 | CN101152570B Epitope vaccine of hog cholera virus and its preparing process |
| 11/24/2010 | CN101139393B KDR peptides and vaccines containing the same |
| 11/24/2010 | CN101028515B Anti-preisz bacterium and gingival carbon dioxide fibrophilic bacterium mixed IgY and its use in treating ozostomia and gingiva |
| 11/23/2010 | US7838648 Purified SR-p70 protein |
| 11/23/2010 | US7838645 Function of autophagy genes in cell death |
| 11/23/2010 | US7838639 antibody that specifically binds to a human TNF Receptor in the BRAIN (TRAIN) polypeptide; useful in regulating cell differentiation, death, and survival |
| 11/23/2010 | US7838637 Single-chain multiple antigen-binding molecule, its preparation and use |
| 11/23/2010 | US7838635 CD16A binding proteins and use for the treatment of immune disorders |
| 11/23/2010 | US7838561 administering to mammal or higher vertebrate an effective amount of a pharmaceutical composition comprising N-[4-hydroxyphenyl]retinamide |
| 11/23/2010 | US7838519 Maytansinoid analogs as antitumor agents |
| 11/23/2010 | US7838489 tumor necrosis factor (TNF) receptors, immunoglobuin fusion proteins; anti-tumor necrosis factor antibodies; Crohn's disease, and acute and chronic immune diseases associated with transplantation |
| 11/23/2010 | US7838289 Assay utilizing multipotent adult stem cells |
| 11/23/2010 | US7838277 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 11/23/2010 | US7838266 A purified pro-cytolytic peptide; used to treat localized and metastatic prostate cancer; administered intratumorally and/or intraprostatically |
| 11/23/2010 | US7838052 Pine cone extracts and uses thereof |
| 11/23/2010 | US7838041 autologously transplanting hematopoietic progenitor cell population which has been treated with antibody (monoclonal, chimeric, or humanized; not conjugated to toxin or cytolytic agent); radiotherapy |
| 11/23/2010 | US7838019 Use of iscom particle(s) as adjuvant in a formulation of vaccine antigens, which comprise at least one iscom-iscom matrix particle together with a non-replicating vaccine antigen and one or more living micro-organisms; enhanced immune response against live vaccine components |
| 11/23/2010 | US7838018 Quaternary hydrocarbon ammonium halogenide and monophosphoryl lipid; synergistic potentiation; kits; tuberculosis |
| 11/23/2010 | US7838016 Vibrio cholerae strains VCUSM1 and VCUSM4, method of producing same, and vaccine derivatives thereof |
| 11/23/2010 | US7838015 Adjuvanted meningococcus compositions |
| 11/23/2010 | US7838014 isolated Neisserial bleb preparation from an engineered Neisserial strain with an L3 LOS immunotype wherein the IgtB gene has been inactivated resulting in an intermediate LOS structure in which the terminal galactose residue and sialic acid are absent |
| 11/23/2010 | US7838013 Specific epitope based immunological diagnosis of tuberculosis |